Novavax – another nanoparticle Covid vaccine
Updated: 2021-03-14 21:54:21
The results for the phase III trial of the Novavax Covid vaccine are now out, and the news seems very good – an overall efficacy of about 90% in the UK trial, with complete protection against severe disease and death. The prospects now look very promising for regulatory approval. What’s striking about this is that … Continue reading "Novavax – another nanoparticle Covid vaccine"